Murphy Matthew B.

Murphy Matthew B. is listed in filings as General Counsel at Nautilus Biotechnology, Inc.. This profile follows SEC Form 4 activity through Mar 4, 2026, including purchase activity. Recent filings connect the profile to Nautilus Biotechnology, Inc. (NAUT). The current snapshot covers public activity from Mar 4, 2025 to Mar 4, 2026. Reported amounts are shown as $371.2K to $198.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.